guhjy's Guyatt:G [46 articles] Export Sort

Recent papers posted to guhjy's library by the author Guyatt:G. You can also see everyone's Guyatt:G.

Hide details

	The minimal detectable change cannot reliably replace the minimal important difference [My Copy] Journal of Clinical Epidemiology (01 October 2009) by Dan Turner, Holger J. Schünemann, Lauren E. Griffith, et al.Dorcas E. Beaton, Anne M. Griffiths, Jeffrey N. Critch, Gordon H. Guyatt posted to change by guhjy on 2009-12-02 16:06:54 as along with 1 person radagabriel
	Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. [My Copy] BMJ (Clinical research ed.), Vol. 338, No. feb16_1. (16 February 2009), b92. by Matthias Briel, Ignacio Ferreira-Gonzalez, John J. You, et al.Paul J. Karanicolas, Elie A. Akl, Ping Wu, Boris Blechacz, Dirk Bassler, Xinge Wei, Asheer Sharman, Irene Whitt, Suzana Alves da Silva, Zahira Khalid, Alain J. Nordmann, Qi Zhou, Stephen D. Walter, Noah Vale, Neera Bhatnagar, Christopher O'Regan, Edward J. Mills, Heiner C. Bucher, Victor M. Montori, Gordon H. Guyatt posted to hdl cv by guhjy on 2009-11-18 02:33:24 as along with 2 people kuchnir mvdijk
	"Pragmatic" clinical trials: from whose perspective? [My Copy] Evidence-based medicine, Vol. 14, No. 5. (1 October 2009), pp. 130-131. by Paul J. Karanicolas, Victor M. Montori, Holger Schünemann, Gordon H. Guyatt posted to pct by guhjy on 2009-11-05 05:22:31 as along with 1 person radagabriel
	2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients. [My Copy] Polskie archiwum medycyny wewnȩtrznej, Vol. 119, No. 9. (September 2009), pp. 541-549. by Roman Jaeschke, Piotr Gajewski, Shannon M. Bates, et al.James Douketis, Bogdan Solnica, Mark Crowther, Wiktoria Leśniak, Jan L. Brozek, Holger J. Schünemann, Krystyna Zawilska, Witold Tomkowski, Anetta Undas, Jan Sznajd, Rafał Nizankowski, Małgorzata M. Bała, Gordon Guyatt posted to gdl dvt by guhjy on 2009-11-03 08:31:02 as
	Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison. [My Copy] Trials, Vol. 10, No. 1. (21 September 2009), 86. by Christopher O'Regan, Isabella Ghement, Oghenowede Eyawo, Gordon H. Guyatt, Edward J. Mills posted to rct indirect by guhjy on 2009-10-07 09:20:15 as
	Tips for learners of evidence-based medicine: 5. The effect of spectrum of disease on the performance of diagnostic tests [My Copy] CMAJ, Vol. 173, No. 4. (16 August 2005), pp. 385-390. by Victor M. Montori, Peter Wyer, Thomas B. Newman, Sheri Keitz, Gordon Guyatt, for The Evidence-Based Medicine Teaching Tips Working Group posted to test ebm by guhjy on 2009-10-04 08:39:57 as along with 1 person textoris
	The practicalists' response. [My Copy] Journal of clinical epidemiology, Vol. 62, No. 5. (May 2009), pp. 489-494. by Paul J. Karanicolas, Victor M. Montori, P. J. Devereaux, Holger Schünemann, Gordon H. Guyatt posted to pct by guhjy on 2009-09-27 15:59:38 as along with 1 person balshemh
	A new 'Mechanistic-Practical” Framework for designing and interpreting randomized trials [My Copy] Journal of Clinical Epidemiology, Vol. 62, No. 5. (May 2009), pp. 479-484. by Paul J. Karanicolas, Victor M. Montori, P. J. Devereaux, Holger Schünemann, Gordon H. Guyatt posted to pct by guhjy on 2009-09-27 15:57:42 as along with 1 person balshemh
	The rational clinical examination. Is this patient having a myocardial infarction? [My Copy] JAMA : the journal of the American Medical Association, Vol. 280, No. 14. (14 October 1998), pp. 1256-1263. by A. A. Panju, B. R. Hemmelgarn, G. H. Guyatt, D. L. Simel posted to pe cv ami by guhjy on 2009-09-13 08:25:50 as
	LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. [My Copy] Trials, Vol. 10 (11 June 2009), 40. by E. A. Akl, M. Briel, J. J. You, et al.F. Lamontagne, A. Gangji, T. Cukierman-Yaffe, M. Alshurafa, X. Sun, K. A. Nerenberg, B. C. Johnston, C. Vera, E. J. Mills, D. Bassler, A. Salazar, N. Bhatnagar, J. W. Busse, Z. Khalid, S. Walter, D. J. Cook, H. J. Schünemann, D. G. Altman, G. H. Guyatt posted to meta-analysis missing rct by guhjy on 2009-07-12 13:57:39 as
	Design, analysis, and presentation of crossover trials. [My Copy] Trials, Vol. 10 (30 April 2009), 27. by Edward J. Mills, An-Wen W. Chan, Ping Wu, Andy Vail, Gordon H. Guyatt, Douglas G. Altman posted to crossover by guhjy on 2009-07-12 13:47:18 as
	How to use an article about genetic association: C: What are the results and will they help me in caring for my patients? [My Copy] JAMA : the journal of the American Medical Association, Vol. 301, No. 3. (21 January 2009), pp. 304-308. by J. Attia, J. P. Ioannidis, A. Thakkinstian, et al.M. McEvoy, R. J. Scott, C. Minelli, J. Thompson, C. Infante-Rivard, G. Guyatt posted to association genetics snp stats by guhjy on 2009-05-31 00:59:23 as along with 2 people floatingpoint daforerog
	Evaluating Agreement: Conducting a Reliability Study [My Copy] J Bone Joint Surg Am, Vol. 91, No. Supplement_3. (1 May 2009), pp. 99-106. by Paul J. Karanicolas, Mohit Bhandari, Hans Kreder, et al.Antonio Moroni, Martin Richardson, Stephen D. Walter, Geoff R. Norman, Gordon H. Guyatt, On posted to agreement by guhjy on 2009-05-19 04:31:07 as
	Incorporating considerations of resources use into grading recommendations [My Copy] BMJ, Vol. 336, No. 7654. (24 May 2008), pp. 1170-1173. by Gordon H. Guyatt, Andrew D. Oxman, Regina Kunz, et al.Roman Jaeschke, Mark Helfand, Alessandro Liberati, Gunn E. Vist, Holger J. Schunemann, For posted to gdl grade by guhjy on 2009-04-10 05:33:37 as along with 1 person dubhousing
	Going from evidence to recommendations [My Copy] BMJ, Vol. 336, No. 7652. (10 May 2008), pp. 1049-1051. by Gordon H. Guyatt, Andrew D. Oxman, Regina Kunz, et al.Yngve Falck-Ytter, Gunn E. Vist, Alessandro Liberati, Holger J. Schunemann, for the GRADE Working Group posted to gdl grade by guhjy on 2009-04-10 05:33:31 as along with 2 people cucherat dubhousing
	Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive [My Copy] BMJ, Vol. 337, No. jul31_1. (31 July 2008), a744. by Roman Jaeschke, Gordon H. Guyatt, Phil Dellinger, et al.Holger Schunemann, Mitchell M. Levy, Regina Kunz, Susan Norris, Julian Bion, For posted to gdl grade by guhjy on 2009-04-10 05:33:24 as along with 1 person dubhousing
	Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions [My Copy] Allergy, Vol. 64, No. 5., pp. 669-677. by J. L. Brozek, E. A. Akl, P. Alonso-Coello, et al.D. Lang, R. Jaeschke, J. W. Williams, B. Phillips, M. Lelgemann, A. Lethaby, J. Bousquet, G. H. Guyatt, H. J. Schunemann posted to gdl grade by guhjy on 2009-04-10 03:52:26 as
	Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. [My Copy] BMC Health Serv Res, Vol. 5, No. 1. (23 March 2005) by D. Atkins, P. A. Briss, M. Eccles, et al.S. Flottorp, G. H. Guyatt, R. T. Harbour, S. Hill, R. Jaeschke, A. Liberati, N. Magrini, J. Mason, D. O'Connell, A. D. Oxman, B. Phillips, H. Schünemann, T. T. Edejer, G. E. Vist, J. W. Williams, posted to ebm grade by guhjy on 2009-04-10 03:18:33 as along with 2 people boncite hslscm
	Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. [My Copy] BMC Health Serv Res, Vol. 4, No. 1. (22 December 2004) by D. Atkins, M. Eccles, S. Flottorp, et al.G. H. Guyatt, D. Henry, S. Hill, A. Liberati, D. O'Connell, A. D. Oxman, B. Phillips, H. Schünemann, T. T. Edejer, G. E. Vist, J. W. Williams, posted to ebm grade by guhjy on 2009-04-10 03:18:16 as along with 1 person murphy
	Choice of data extraction tools for systematic reviews depends on resources and review complexity. [My Copy] Journal of clinical epidemiology, Vol. 62, No. 5. (May 2009), pp. 506-510. by Mohamed B. Elamin, David N. Flynn, Dirk Bassler, et al.Matthias Briel, Pablo Alonso-Coello, Paul Jack J. Karanicolas, Gordon H. Guyatt, German Malaga, Toshiaki A. Furukawa, Regina Kunz, Holger Schünemann, Mohammad Hassan H. Murad, Corrado Barbui, Andrea Cipriani, Victor M. Montori posted to meta-analysis by guhjy on 2009-04-09 11:29:57 as along with 4 people and 1 group msampson danielhind cm1acb kharke Systematic Reviews Academic Development Group
	Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference. [My Copy] Journal of clinical epidemiology, Vol. 62, No. 4. (April 2009), pp. 374-379. by D. Turner, H. J. Schünemann, L. E. Griffith, et al.D. E. Beaton, A. M. Griffiths, J. N. Critch, G. H. Guyatt posted to roc by guhjy on 2009-03-25 03:58:30 as
	How to use an article about genetic association: B: Are the results of the study valid? [My Copy] JAMA : the journal of the American Medical Association, Vol. 301, No. 2. (14 January 2009), pp. 191-197. by J. Attia, J. P. Ioannidis, A. Thakkinstian, et al.M. McEvoy, R. J. Scott, C. Minelli, J. Thompson, C. Infante-Rivard, G. Guyatt posted to association genetics snp stats by guhjy on 2009-02-18 02:41:26 as along with 3 people druvus floatingpoint daforerog
	How to use an article about genetic association: A: Background concepts. [My Copy] JAMA : the journal of the American Medical Association, Vol. 301, No. 1. (7 January 2009), pp. 74-81. by J. Attia, J. P. Ioannidis, A. Thakkinstian, et al.M. McEvoy, R. J. Scott, C. Minelli, J. Thompson, C. Infante-Rivard, G. Guyatt posted to association genetics snp stats by guhjy on 2009-02-18 02:35:54 as along with 6 people floatingpoint druvus booker daforerog lynnefox wimufi
	Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? [My Copy] International journal of epidemiology, Vol. 38, No. 1. (February 2009), pp. 276-286. by Kristian Thorlund, P. J. Devereaux, Jørn Wetterslev, et al.Gordon Guyatt, John P. Ioannidis, Lehana Thabane, Lise-Lotte L. Gluud, Bodil Als-Nielsen, Christian Gluud posted to meta-analysis tsa by guhjy on 2009-02-05 08:57:04 as
	Systematic reviewers commonly contact study authors but do so with limited rigor [My Copy] Journal of Clinical Epidemiology, Vol. 62, No. 2. (February 2009), pp. 138-142. by R. Mullan, D. Flynn, B. Carlberg, et al.I. Tleyjeh, C. Kamath, M. Labella, P. Erwin, G. Guyatt, V. Montori posted to meta-analysis by guhjy on 2009-01-30 04:28:12 as along with 1 person chainsawriot
	Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. [My Copy] JAMA : the journal of the American Medical Association, Vol. 285, No. 15. (18 April 2001), pp. 2000-2003. by P. J. Devereaux, B. J. Manns, W. A. Ghali, et al.H. Quan, C. Lacchetti, V. M. Montori, M. Bhandari, G. H. Guyatt posted to blinding rct by guhjy on 2009-01-26 12:17:11 as
	In the dark: the reporting of blinding status in randomized controlled trials. [My Copy] Journal of clinical epidemiology, Vol. 55, No. 8. (August 2002), pp. 787-790. by V. M. Montori, M. Bhandari, P. J. Devereaux, B. J. Manns, W. A. Ghali, G. H. Guyatt posted to blinding rct by guhjy on 2009-01-26 12:16:52 as
	An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. [My Copy] Journal of clinical epidemiology, Vol. 57, No. 12. (December 2004), pp. 1232-1236. by P. J. Devereaux, P. T. Choi, S. El-Dika, et al.M. Bhandari, V. M. Montori, H. J. Schünemann, A. X. Garg, J. W. Busse, D. Heels-Ansdell, W. A. Ghali, B. J. Manns, G. H. Guyatt posted to blinding rct by guhjy on 2009-01-26 09:17:56 as
	What is "quality of evidence" and why is it important to clinicians? [My Copy] BMJ, Vol. 336, No. 7651. (3 May 2008), pp. 995-998. by Gordon H. Guyatt, Andrew D. Oxman, Regina Kunz, et al.Gunn E. Vist, Yngve Falck-Ytter, Holger J. Schunemann, For posted to gdl grade by guhjy on 2009-01-14 10:16:30 as along with 2 people dubhousing rd49
	A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System [My Copy] J Clin Endocrinol Metab, Vol. 93, No. 3. (1 March 2008), pp. 666-673. by Brian A. Swiglo, M. H. Murad, Holger J. Schunemann, et al.Regina Kunz, Robert A. Vigersky, Gordon H. Guyatt, Victor M. Montori posted to gdl grade by guhjy on 2009-01-11 06:44:20 as
	Validity of composite end points in clinical trials [My Copy] BMJ, Vol. 330, No. 7491. (12 March 2005), pp. 594-596. by Victor M. Montori, Gaieta Permanyer-Miralda, Ignacio Ferreira-Gonzalez, et al.Jason W. Busse, Valeria Pacheco-Huergo, Dianne Bryant, Jordi Alonso, Elie A. Akl, Antonia Domingo-Salvany, Edward Mills, Ping Wu, Holger J. Schunemann, Roman Jaeschke, Gordon H. Guyatt posted to end-point composite rct by guhjy on 2009-01-03 14:49:18 as
	GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. [My Copy] BMJ (Clinical research ed.), Vol. 336, No. 7650. (26 April 2008), pp. 924-926. by G. H. Guyatt, A. D. Oxman, G. E. Vist, et al.R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, H. J. Schünemann, posted to gdl ebm by guhjy on 2008-12-06 08:11:50 as along with 1 person dubhousing
	Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. [My Copy] BMJ (Clinical research ed.), Vol. 334, No. 7597. (14 April 2007) by I. Ferreira-González, J. W. Busse, D. Heels-Ansdell, et al.V. M. Montori, E. A. Akl, D. M. Bryant, P. Alonso-Coello, J. Alonso, A. Worster, S. Upadhye, R. Jaeschke, H. J. Schünemann, G. Permanyer-Miralda, V. Pacheco-Huergo, A. Domingo-Salvany, P. Wu, E. J. Mills, G. H. Guyatt posted to arb composite creatinine end-point multiplicity rct by guhjy on 2008-10-01 16:17:44 as
	Tips for teachers of evidence-based medicine: understanding odds ratios and their relationship to risk ratios. [My Copy] Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine, Vol. 23, No. 5. (May 2008), pp. 635-640. by K. Prasad, R. Jaeschke, P. Wyer, S. Keitz, G. Guyatt, posted to ebm by guhjy on 2008-09-16 04:34:37 as along with 1 person gareth
	Misconceptions, challenges, uncertainty, and progress in guideline recommendations. [My Copy] Seminars in hematology, Vol. 45, No. 3. (July 2008), pp. 167-175. by R. Kunz, B. Djulbegovic, H. J. Schunemann, M. Stanulla, P. Muti, G. Guyatt posted to gdl uncertainty by guhjy on 2008-07-15 11:18:28 as
	Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. [My Copy] BMJ (Clinical research ed.), Vol. 336, No. 7653. (17 May 2008), pp. 1106-1110. by H. J. Schünemann, A. D. Oxman, J. Brozek, et al.P. Glasziou, R. Jaeschke, G. E. Vist, J. W. Williams, R. Kunz, J. Craig, V. M. Montori, P. Bossuyt, G. H. Guyatt, posted to test ebm grade by guhjy on 2008-06-14 04:13:34 as along with 2 people dubhousing rd49
	Association between unreported outcomes and effect size estimates in Cochrane meta-analyses. [My Copy] JAMA : the journal of the American Medical Association, Vol. 297, No. 5. (7 February 2007), pp. 468-470. by T. A. Furukawa, N. Watanabe, I. M. Omori, V. M. Montori, G. H. Guyatt posted to rct by guhjy on 2008-06-12 05:11:00 as
	Patient-important outcomes in registered diabetes trials. [My Copy] JAMA : the journal of the American Medical Association, Vol. 299, No. 21. (4 June 2008), pp. 2543-2549. by G. Y. Gandhi, M. H. Murad, A. Fujiyoshi, et al.R. J. Mullan, D. N. Flynn, M. B. Elamin, B. A. Swiglo, W. L. Isley, G. H. Guyatt, V. M. Montori posted to dm end-point quality rct surrogate by guhjy on 2008-06-10 11:28:46 as
	Early stopping of randomized clinical trials for overt efficacy is problematic [My Copy] Journal of Clinical Epidemiology, Vol. 61, No. 3. (March 2008), pp. 241-246. by Dirk Bassler, Victor M. Montori, Matthias Briel, Paul Glasziou, Gordon Guyatt posted to no-tag by guhjy on 2008-02-04 03:43:31 as
	In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter. [My Copy] PLoS Med, Vol. 5, No. 1. (3 January 2008) by Gordon H H. Guyatt, Edward J J. Mills, Diana Elbourne posted to no-tag by guhjy on 2008-01-09 02:42:34 as
	Tips for Teachers of Evidence-Based Medicine: Adjusting for Prognostic Imbalances (Confounding Variables) in Studies on Therapy or Harm. [My Copy] J Gen Intern Med (3 January 2008) by Cassie C. Kennedy, Roman Jaeschke, Sheri Keitz, et al.Thomas Newman, Victor Montori, Peter C. Wyer, Gordon Guyatt, posted to ebm by guhjy on 2008-01-09 02:42:23 as
	Which patients to include in the analysis? [My Copy] Transfusion, Vol. 46, No. 6. (June 2006), pp. 881-884. by R. Kunz, G. Guyatt posted to no-tag by guhjy on 2007-12-14 10:28:49 as
	Randomized trials stopped early for benefit: a systematic review. [My Copy] JAMA, Vol. 294, No. 17. (2 November 2005), pp. 2203-2209. by V. M. Montori, P. J. Devereaux, N. K. Adhikari, et al.K. E. Burns, C. H. Eggert, M. Briel, C. Lacchetti, T. W. Leung, E. Darling, D. M. Bryant, H. C. Bucher, H. J. Schünemann, M. O. Meade, D. J. Cook, P. J. Erwin, A. Sood, R. Sood, B. Lo, C. A. Thompson, Q. Zhou, E. Mills, G. H. Guyatt posted to meta-analysis rct by guhjy on 2007-09-11 03:43:08 as
	Users' guide to detecting misleading claims in clinical research reports. [My Copy] BMJ, Vol. 329, No. 7474. (6 November 2004), pp. 1093-1096. by V. M. Montori, R. Jaeschke, H. J. Schünemann, et al.M. Bhandari, J. L. Brozek, P. J. Devereaux, G. H. Guyatt posted to ebm rct by guhjy on 2007-08-14 11:17:34 as
	Basic statistics for clinicians: 4. Correlation and regression. [My Copy] CMAJ, Vol. 152, No. 4. (15 February 1995), pp. 497-504. by G. Guyatt, S. Walter, H. Shannon, D. Cook, R. Jaeschke, N. Heddle posted to regression by guhjy on 2007-08-12 13:53:15 as
	Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. [My Copy] J Clin Epidemiol, Vol. 60, No. 7. (July 2007) by I. Ferreira-González, G. Permanyer-Miralda, J. W. Busse, et al.D. M. Bryant, V. M. Montori, P. Alonso-Coello, S. D. Walter, G. H. Guyatt posted to end-point composite rct by guhjy on 2007-08-12 10:16:03 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/author/Guyatt:G

ckd	1738
rct	1203
dn	1146
dm	1046
cancer	1044
ma	979
cv	926
hd	859
tgfb	841
snp	772
ros	661
bp	644
meta-analysis	516
kidney	507
uae	501
mouse	493
stats	480
software	463
mirna	450
pt	449
genetics	449
proteomics	412
mortality	408
rat	390
fbl	379
tw	373
inflammation	371
proteinuria	356
pcr	353
akt	346
mtor	346
mc	343
1	340
db	337
acei	334
gdl	331
irs	326
test	325
inhibitor	324
method	323
urine	320
arb	316
apoptosis	314
aging	311
age	311
ms	310
hcv	304
aii	299
r	294
biomarker	287
hg	285
ppi	282
bias	277
pi3k	276
bayes	275
gwa	270
aki	269
s6k	262
emt	260
nutrition	255
rnai	249
egfr	249
p53	243
ub	242
obesity	236
fibrosis	236
erk	232
cox	229
smad	228
drug	225
pbmc	223
hcc	216
metab	214
hypoxia	212
gn	210
nfkb	205
herb	204
stz	196
collagen	192
albumin	189
lc	187
hif	184
longitudinal	179
pubmed	179
lmm	178
pkc	175
gfr	174
p38	173
ua	170
epigenetics	169
bioinf	166
japan	165
power	163
cea	163
rage	162
gender	162
dna-damage	161
lead	160
cadmium	158
ref	154
genomics	151
vitamin-d	148
ctgf	147
stata	147
liver	146
book	146
network	146
company	144
screening	137
diet	136
rt	136
phosphorylation	135
mt	133
seq	133
kinase	128
go	128
protein	127
pathway	127
cell-cycle	126
no	126
esrd	124
systems-biology	124
insulin	122
lipid	118
creatinine	117
statin	117
proliferation	113
senescence	109
mapk	109
stat	106
podocyte	106
fish	104
tnf	104
regression	103
gfr-formula	102
cad	102
pd	102
case-control	102
hypertrophy	101
imputation	101
nox	100
multiplicity	100
imaging	100
rx	99
p21	98
observational	98
sirt	97
methylation	96
pediatric	96
pparg	96
cloning	96
plasmid	96
at1	95
recurrent	94
betel	93
blood	93
chf	91
src	90
nhanes	90
website	89
anemia	88
phenotype	88
immunity	88
ko	88
diagnosis	87
toxicology	86
review	86
lr	86
uti	85
gene-therapy	84
epo	84
ebm	84
cytokine	84
china	83
environment	82
ca	81
nonp	81
oat	81
cachexia	81
p	81
hapmap	80
gout	78
autophagy	78
primer	78
qms	77
signaling	75
egf	75
missing	73
promoter	73
ace	73
eif	73
cox2	73
stone	72
lpd	72
surrogate	72
eqtl	72
gene-list	72
gpcr	72
mv	71
p-value	71
col4	71
ampk	71
4ebp	71
salt	70
phd	69
foxo	69
jnk	69
mgo	68
glycemia	66
uncertainty	66
hts	65
chinese	65
pe	65
uuo	65
mirna-target	65
normalization	65
tin	65
shc	64
ifn	64
association	64
enddysf	63
yeast	63
acid-base	63
2dge	63
causation	63
pla2	63
hsp	63
smoking	62
llcpk1	62
simulation	62
nrk49f	62
translation	62
me	62
avf	61
oglcnac	61
pdgf	61
confounding	61
ptm	61
mmp	60
outcome	60
infection	60
change	60
sas	60
melamine	60
pai1	59
oral	59
crp	59
cost	59
alcohol	58
hk2	58
achr	57
rho	57
pls	57
urate-transporter	57
vegf	57
model-selection	57
robust	57
fluorescence	57
aceiarb	56
rapamycin	56
semantic	56
calibration	56
competing-risk	55
goldstd	55
ratio	55
ace2	55
ncrna	55
cyclin-d1	54
workflow	54
function	54
iron	54
ckd-progression	54
stem-cell	54
bone	54
estrogen	54
hsc	53
dipstick	53
renoprotection	53
pld	53
k	53
std	53
dimerization	52
il6	52
tf	52
histone	52
atm	52
qc	52
fgf	52
ab	51
normoalbuminuria	51
epidemiology	51
hdac	51
pth	51
lod	51
matlab	50
risk-ratio	50
hepatocyte	50
arsenic	50
p27	50
graph	50
adpkd	50
reasoning	50
mercury	50
wnt	50
klotho	49
epistasis	49
gene-environment	49
antibiotics	49
core-curriculum	48
ngal	48
ukm	48
pdk	48
irs1	48
ffpe	48
endothelium	48
breakpoint	48
nrk52e	48
spot-urine	47
pooling	47
joint-model	47
mtorc1	47
aspirin	46
ras	46
hgf	46
cystatin	46
dub	46
aldosterone	46
protein-microarray	46
fdr	46
prevention	45
semip	45
fgf23	45
metal	45
biosensor	45
writing	45
dbdb	45
diuretics	44
interaction	44
ecm	44
tgfbr	44
metformin	44
variability	44
er-stress	44
ancova	44
enos	44
mesangial	44
ccb	44
sumo	44
klf	43
bia	43
sle	43
cnv	43
na	43
design	43
asia	42
bmi	42
agreement	42
good	42
roc	42
icu	42
stroke	42
fuzzy	41
qtl	41
catenin	41
vsmc	41
tlr	40
hyperfiltration	40
fibronectin	40
sage	40
alignment	40
gene-targeting	40
risk	40
wga	40
ap1	39
angiogenesis	39
urinalysis	39
dry-bw	39
rca	39
protein-complex	39
igf	39
tea	38
igan	38
myc	38
antisense	38
rvh	38
omics	38
gsk3	37
gsk	37
propensity	37
emr	37
glut	37
adh	37
fabp	37
haplotype	37
bh4	37
hematuria	37
rsk	37
mtorc2	36
snx	36
adenosine	36
proteasome	36
cardiorenal	36
megalin	36
web20	36
il1	36
animal	36
inflammasome	36
s100b	36
chemogenomics	35
sp1	35
coffee	35
candidate-gene	35
exercise	35
annotation	35
subgroup	35
cre	35
adduct	35
reverse-epidemiology	35
threshold	35
calcification	35
nephrotoxicity	34
msm	34
sglt	34
sepsis	34
creb	34
attrition	34
pathology	34
cross-species	34
effect-size	34
pka	33
ecology	33
sarcopenia	33
zeb	33
rtk	33
bmp	33
cage	33
ns	33
integrin	33
affy	32
ai	32
addgene	32
pp2a	32
steroid	32
et	32
set	32
end-point	32
text-mining	32
aa	32
browser	32
zfn	32
fc	32
macrophage	32
orbitrap	32
gllamm	31
frailty	31
family	31
silac	31
agt	31
heritability	31
hospitalization	31
emsa	31
transactivation	31
igf1	31
abp	31
blast	31
risk-difference	31
mw	30
membrane-protein	30
reporter	30
transporter	30
notch	30
grn	30
pten	30
carcinogen	30
s100	30
cr	30
knockout	30
staging	30
geo	30
ub-ligase	29
3	29
perindopril	29
nicotinic	29
validation	29
nutrient	29
virus	29
human	29
sgk	29
extraction	29
renin	29
pharmacogenetics	28
race	28
mutagenesis	28
time-dependent	28
acetylation	28
gee	28
hplc	28
thesis	28
scaling	28

guhjy's Guyatt:G [46 articles] Export Sort

guhjy's tags